Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Short term Debt: 2020-2023

  • Legend Biotech's Short term Debt was N/A to $1.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2022, which is N/A change from last year.
  • As of Q3 2023, Legend Biotech's Short term Debt stood at $1.2 million, which was down 4.28% from $1.2 million recorded in Q2 2023.
  • Over the past 5 years, Legend Biotech's Short term Debt peaked at $6.1 million during Q2 2021, and registered a low of $1.2 million during Q3 2023.
  • Moreover, its 3-year median value for Short term Debt was $1.9 million (2022), whereas its average is $2.8 million.